UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

011 A case of a neurological immune-related adverse event associated with ipilimumab/nivolumab

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2

2022

Volltextzugriff (PDF)

03.05 Towards a B cell vaccine for tumour expressed self-antigens

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A1-A1

2022

Volltextzugriff (PDF)

03.06 Cancer-specific oral microbiotherapy for cancer immunotherapy

Journal for immunotherapy of cancer, 2024-03, Vol.12 (Suppl 1), p.A2-A3

2024

Volltextzugriff (PDF)

03.06 Understanding how epitope binding influences antibody dependent complement engagement for therapy of B-cell malignancies

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A1-A1

2022

Volltextzugriff (PDF)

06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A2-A3

2022

Volltextzugriff (PDF)

061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A31-A31

2022

Volltextzugriff (PDF)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A22-A23

2021

Volltextzugriff (PDF)

064 Imilimumab/nivolumab induced paraspinal myositis causing dysphagia

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A32-A32

Warner, Graham

2022

Volltextzugriff (PDF)

085 Durvalumab-induced fatal myasthenia gravis

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A38-A39

2022

Volltextzugriff (PDF)

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A4-A5

2022

Volltextzugriff (PDF)

1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)

Bioorganic & medicinal chemistry letters, 2016-09, Vol.26 (17), p.4330-4333

2016

Volltextzugriff (PDF)

(1→3)-α-d-Glucooligosaccharides Increase the Killing Capacity of NK Cells against Selected Human Colon Cancer Cells

Molecules (Basel, Switzerland), 2023-05, Vol.28 (10), p.4212

2023

Volltextzugriff (PDF)

1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists

RSC medicinal chemistry, 2024-04, Vol.15 (4), p.121-1215

2024

Volltextzugriff (PDF)

1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy

PloS one, 2010-12, Vol.5 (12), p.e15823-e15823

2010

Volltextzugriff (PDF)

1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer

Oncotarget, 2013-12, Vol.4 (12), p.2397-2406

2013

Volltextzugriff (PDF)

IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy

Immunological reviews, 2018-01, Vol.281 (1), p.57-61

2018

Volltextzugriff (PDF)

1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A1-A1

2020

Volltextzugriff (PDF)

IL-1[beta] mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer

Cell communication and signaling, 2024-08, Vol.22 (1)

2024

Volltextzugriff (PDF)

1 Capturing the spatial landscape of tumor and immune cell lineages in the microenvironment of human cancer tissues

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A1-A1

2022

Volltextzugriff (PDF)

1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression

BMC cancer, 2020-09, Vol.20 (1), p.869-7, Article 869

2020

Volltextzugriff (PDF)

1 Million Movember-Prostate Cancer Foundation Challenge Award Will Fund City of Hope Immunotherapy Research

Business Wire, 2014-01-30

2014

Volltextzugriff (PDF)

1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.148-148, Article 148

2018

Volltextzugriff (PDF)

IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy

The Journal of clinical investigation, 2023-04, Vol.133 (7), p.1-17

2023

Volltextzugriff (PDF)

1 Tumour associated macrophages in HPV-related carcinoma with adenoid cystic like features of the sinonasal tract; a review of three cases

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A1-A1

2020

Volltextzugriff (PDF)

10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells

Journal for immunotherapy of cancer, 2021-10, Vol.9 (Suppl 1), p.A1-A1

2021

Volltextzugriff (PDF)

1 – 25 von 114.002

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90.033)
Mit Volltextzugriff
(85.742)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(112.828)
Japanisch
(8.641)
Französisch
(310)
Deutsch
(283)
Chinesisch
(280)
Russisch
(94)
Spanisch
(94)
Portugiesisch
(89)
Norwegisch
(63)
Türkisch
(41)
Koreanisch
(35)
Polnisch
(21)
Urdu
(21)
Tschechisch
(11)
Italienisch
(11)
Persisch
(5)
Croatian
(4)
Dänisch
(4)
Serbian
(4)
Niederländisch
(3)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Immunotherapy
(102.603)
Science & Technology
(80.167)
Life Sciences & Biomedicine
(73.183)
Cancer
(45.126)
Oncology
(45.118)
Humans
(44.903)
Tumors
(37.933)
Cancer Therapies
(29.974)
Patients
(24.339)
Chemotherapy
(23.646)
Metastasis
(21.005)
Lymphocytes
(20.769)
Immunology
(19.713)
Monoclonal Antibodies
(16.861)
Antigens
(16.662)
Animals
(16.514)
Clinical Trials
(16.299)
Medical Prognosis
(15.819)
Female
(15.731)
Lung Cancer
(13.362)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(61.497)
MEDLINE
(49.615)
Ingenta
(44.543)
IngentaConnect Journals
(30.069)
Journals@Ovid
(26.947)
Springer Online Journals
(24.013)
Nexis Uni (LexisNexis)
(21.915)
Wiley Online Library
(10.978)
Elsevier ScienceDirect Journals Complete
(9.130)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(8.859)
Publisher or Other Site
(8.790)
British Medical Journals Online Archive (BMJ)
(7.524)
Taylor & Francis Journals Auto-Holdings Collection
(6.420)
North East Research Libraries Nature Academic Titles
(6.367)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(6.296)
Wiley Online Library Full Collection 2018
(5.910)
Taylor & Francis
(4.389)
Taylor & Francis:Master (3349 titles)
(2.619)
SAGE Journals
(1.338)
Ebook Central Perpetual and DDA
(1.006)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal For Immunotherapy Of Cancer
(6.091)
Cancers
(3.979)
Cancer Immunology, Immunotherapy
(2.986)
Cancer Immunology Immunotherapy
(2.762)
Cancer Immunology, Immunotherapy : Cii
(2.385)
Pr Newswire
(2.167)
Business Wire
(2.047)
International Journal Of Molecular Sciences
(1.791)
Plos One
(1.719)
Frontiers In Immunology
(1.680)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

011 A case of a neurological immune-related adverse event associated with ipilimumab/nivolumab

03.05 Towards a B cell vaccine for tumour expressed self-antigens

03.06 Cancer-specific oral microbiotherapy for cancer immunotherapy

03.06 Understanding how epitope binding influences antibody dependent complement engagement for therapy of B-cell malignancies

06.04 Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer

062 Pembrolizumab induced lambert-eaton myasthenic syndrome

064 Imilimumab/nivolumab induced paraspinal myositis causing dysphagia

085 Durvalumab-induced fatal myasthenia gravis

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)

(1→3)-α-d-Glucooligosaccharides Increase the Killing Capacity of NK Cells against Selected Human Colon Cancer Cells

1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists

1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy

1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer

IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy

1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial

IL-1[beta] mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer

1 Capturing the spatial landscape of tumor and immune cell lineages in the microenvironment of human cancer tissues

1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression

1 Million Movember-Prostate Cancer Foundation Challenge Award Will Fund City of Hope Immunotherapy Research

1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis

IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy

1 Tumour associated macrophages in HPV-related carcinoma with adenoid cystic like features of the sinonasal tract; a review of three cases

10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells

Suchergebnisse filtern